Maximizing value through packaging optimization for inflammatory condition treatments
Background:
A brand name treatment that may be used to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and other inflammatory conditions is available as a 1-syringe (150mg) pack and a 2-syringe (150mg each) pack; both cost the same.
Opportunity:
We identified members using 150mg of the treatment monthly and recommended a switch to ensure that they are receiving the most cost-effective package size available.
Result:
It is more cost-effective to use the 2-syringe pack for a two-month supply due to the flat pricing of the medication. This simple package size change led to significant savings for the client.
Savings:
Average Savings per Conversion: $45,000
Want to see how you could save? Contact us for an ROI guarantee proposal to see.
Results may vary based on formulary design. Past results do not guarantee future results.